Gadolinium-Enhanced 3D T1-Weighted Black-Blood MR Imaging for the Detection of Acute Optic Neuritis

References

1. 1.↵
   1. Francis DA,
   2. Compston DA,
   3. Batchelor JR, et al

   . A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987;50:758–65 doi:10.1136/jnnp.50.6.758 pmid:3497228

   Abstract/FREE Full Text
2. 2.↵
   1. Rizzo JF 3rd.,
   2. Lessell S

   . Risk of developing multiple sclerosis after uncomplicated optic neuritis: a long-term prospective study. Neurology 1988;38:185–90 doi:10.1212/wnl.38.2.185 pmid:3340278

   Abstract/FREE Full Text
3. 3.↵
   1. Hickman SJ,
   2. Dalton CM,
   3. Miller DH, et al

   . Management of acute optic neuritis. Lancet 2002;360:1953–62 doi:10.1016/s0140-6736(02)11919-2 pmid:12493277

   CrossRefPubMedWeb of Science
4. 4.
   1. Toosy AT,
   2. Mason DF,
   3. Miller DH

   . Optic neuritis. Lancet Neurol 2014;13:83–99 doi:10.1016/S1474-4422(13)70259-X pmid:24331795

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Wikstrom J,
   2. Poser S,
   3. Ritter G

   . Optic neuritis as an initial symptom in multiple sclerosis. Acta Neurol Scand 1980;61:178–85 doi:10.1111/j.1600-0404.1980.tb01480.x pmid:7395462

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Filippi M,
   2. Rocca MA,
   3. Ciccarelli O, et al

   ; MAGNIMS Study Group. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 2016;15:292–303 doi:10.1016/S1474-4422(15)00393-2 pmid:26822746

   CrossRefPubMed
7. 7.↵
   1. Thompson AJ,
   2. Banwell BL,
   3. Barkhof F, et al

   . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162–73 doi:10.1016/S1474-4422(17)30470-2 pmid:29275977

   CrossRefPubMed
8. 8.↵
   1. Petzold A,
   2. Wattjes MP,
   3. Costello F, et al

   . The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 2014;10:447–58 doi:10.1038/nrneurol.2014.108 pmid:25002105

   CrossRefPubMed
9. 9.↵
   1. Hadhoum N,
   2. Hodel J,
   3. Defoort-Dhellemmes S, et al

   . Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss. Mult Scler 2016;22:649–58 doi:10.1177/1352458515598021 pmid:26227005

   CrossRefPubMed
10. 10.↵
    1. Hodel J,
    2. Outteryck O,
    3. Bocher AL, et al

    . Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study. Eur Radiol 2014;24:3069–75 doi:10.1007/s00330-014-3342-3 pmid:25149294

    CrossRefPubMed
11. 11.↵
    1. Riederer I,
    2. Muhlau M,
    3. Hoshi MM, et al

    . Detecting optic nerve lesions in clinically isolated syndrome and multiple sclerosis: double-inversion recovery magnetic resonance imaging in comparison with visually evoked potentials. J Neurol 2019;266:148–56 doi:10.1007/s00415-018-9114-2 pmid:30446963

    CrossRefPubMed
12. 12.↵
    1. Kupersmith MJ,
    2. Alban T,
    3. Zeiffer B, et al

    . Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 2002;125:812–22 doi:10.1093/brain/awf087 pmid:11912114

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Sommer NN,
    2. Saam T,
    3. Coppenrath E, et al

    . Multiple sclerosis: improved detection of active cerebral lesions with 3-dimensional T1 black-blood magnetic resonance imaging compared with conventional 3-dimensional T1 GRE imaging. Invest Radiol 2018;53:13–19 doi:10.1097/RLI.0000000000000410 pmid:28858894

    CrossRefPubMed
14. 14.↵
    1. Park J,
    2. Kim J,
    3. Yoo E, et al

    . Detection of small metastatic brain tumors: comparison of 3D contrast-enhanced whole-brain black-blood imaging and MP-RAGE imaging. Invest Radiol 2012;47:136–41 doi:10.1097/RLI.0b013e3182319704 pmid:22104961

    CrossRefPubMed
15. 15.↵
    1. Yoneyama M,
    2. Nakamura M,
    3. Tabuchi T, et al

    . Whole-brain black-blood imaging with magnetization-transfer prepared spin echo-like contrast: a novel sequence for contrast-enhanced brain metastasis screening at 3T. Radiol Phys Technol 2013;6:431–36 doi:10.1007/s12194-013-0216-3 pmid:23645471

    CrossRefPubMed
16. 16.↵
    1. Kammer NN,
    2. Coppenrath E,
    3. Treitl KM, et al

    . Comparison of contrast-enhanced modified T1-weighted 3D TSE black-blood and 3D MP-RAGE sequences for the detection of cerebral metastases and brain tumours. Eur Radiol 2016;26:1818–25 doi:10.1007/s00330-015-3975-x pmid:26334511

    CrossRefPubMed
17. 17.↵
    1. Treitl KM,
    2. Treitl M,
    3. Kooijman-Kurfuerst H, et al

    . Three-dimensional black-blood T1-weighted turbo spin-echo techniques for the diagnosis of deep vein thrombosis in comparison with contrast enhanced magnetic resonance imaging: a pilot study. Invest Radiol 2015;50:401–08 doi:10.1097/RLI.0000000000000142 pmid:25783228

    CrossRefPubMed
18. 18.↵
    1. Edelman RR,
    2. Chien D,
    3. Kim D

    . Fast selective black-blood MR imaging. Radiology 1991;181:655–60 doi:10.1148/radiology.181.3.1947077 pmid:1947077

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Edelman RR,
    2. Mattle HP,
    3. Wallner B, et al

    . Extracranial carotid arteries: evaluation with “black-blood” MR angiography. Radiology 1990;177:45–50 doi:10.1148/radiology.177.1.2399337 pmid:2399337

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Treitl KM,
    2. Maurus S,
    3. Sommer NN, et al

    . 3D-black-blood 3T-MRI for the diagnosis of thoracic large vessel vasculitis: a feasibility study. Eur Radiol 2017;27:2119–28 doi:10.1007/s00330-016-4525-x pmid:27510630

    CrossRefPubMed
21. 21.↵
    1. Sommer NN,
    2. Treitl KM,
    3. Coppenrath E, et al

    . Three-dimensional high-resolution black-blood magnetic resonance imaging for detection of arteritic anterior ischemic optic neuropathy in patients with giant cell arteritis. Invest Radiol 2018;53:698–704 doi:10.1097/RLI.0000000000000500 pmid:30095558

    CrossRefPubMed
22. 22.↵
    1. Riederer I,
    2. Karampinos DC,
    3. Settles M, et al

    . Double inversion recovery sequence of the cervical spinal cord in multiple sclerosis and related inflammatory diseases. AJNR Am J Neuroradiol 2015;36:219–25 doi:10.3174/ajnr.A4093 pmid:25169924

    Abstract/FREE Full Text
23. 23.↵
    1. Edelstein WA,
    2. Glover GH,
    3. Hardy CJ, et al

    . The intrinsic signal-to-noise ratio in NMR imaging. Magn Reson Med 1986;3:604–18 doi:10.1002/mrm.1910030413 pmid:3747821

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Park J,
    2. Kim EY

    . Contrast-enhanced, three-dimensional, whole-brain, black-blood imaging: application to small brain metastases. Magn Reson Med 2010;63:553–61 doi:10.1002/mrm.22261 pmid:20187162

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Pino-Lopez L,
    2. Wenz H,
    3. Bohme J, et al

    . Contrast-enhanced fat-suppressed FLAIR for the characterization of leptomeningeal inflammation in optic neuritis. Mult Scler 2019;25:792–800 doi:10.1177/1352458518770268 pmid:29683029

    CrossRefPubMed
26. 26.↵
    1. Uysal E,
    2. Erturk SM,
    3. Yildirim H, et al

    . Sensitivity of immediate and delayed gadolinium enhanced MRI after injection of 0.5 M and 1.0 M gadolinium chelates for detecting multiple sclerosis lesions. AJR Am J Roentgenol 2007;188:697–702 doi:10.2214/AJR.05.2212 pmid:17312056

    CrossRefPubMed